§ PHARMACEUTICALS
USD · PharmaceuticalsELAN
ELANCO ANIMAL HEALTH INC
USDSector · PharmaceuticalsBeta · 1.91
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
OPEN 22.32HIGH 22.50LOW 21.6252W 8.02 — 27.72
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
250 increased/new, 215 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 1.72 | EPS (TTM) | -0.48 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Dodge & Cox | 68.9M | 0.9% | −13% |
| Fidelity Management | 50.9M | 0.1% | −2% |
| BlackRock, Inc. | 47.6M | 0.0% | +3% |
| PRIMECAP MANAGEMENT CO/CA/ | 45.8M | 0.9% | −1% |
| Dimensional Fund Advisors | 24.5M | 0.1% | −2% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 22.6M | n/a | n/a |
◇ AC INTELLIGENCE
Top institutional owners for ELAN as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER37.2% · 389 holders
QUALITY / COMPOUNDER32.2% · 33 holders
DEEP VALUE15.8% · 3 holders
PASSIVE / INDEX14.9% · 10 holders
DEALER / BANK10.1% · 39 holders
INCOME / DEFENSIVE2.8% · 31 holders
TACTICAL / MACRO1.1% · 3 holders
SYSTEMATIC / QUANT0.9% · 8 holders
ACTIVIST0.0% · 1 holder
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for ELAN in the last 180 days.